AKBA earnings: a negative outcome, -10.3%

On May 9, 2022, Akebia Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -10.3% in the window around the event. It had already run -29.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.